title: Outcome of fluocinolone acetonide implant (Retisert) reimplantation for chronic noninfectious posterior uveitis.
authors.affiliation: Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
authors.forename: Mehran
authors.initials: M
authors.lastname: Taban
authors.forename: Careen Y
authors.initials: CY
authors.lastname: Lowder
authors.forename: Peter K
authors.initials: PK
authors.lastname: Kaiser
mesh_terms: D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002387:Cataract Extraction; D002908:Chronic Disease; D004343:Drug Implants / Q000009:adverse effects; D005260:Female; D005446:Fluocinolone Acetonide / Q000008:administration & dosage* / Q000009:adverse effects; D005500:Follow-Up Studies; D005901:Glaucoma / Q000139:chemically induced / Q000601:surgery; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012163:Retinal Detachment / Q000209:etiology / Q000601:surgery; D012167:Retinal Perforations / Q000139:chemically induced / Q000150:complications; D019233:Retreatment; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D015866:Uveitis, Posterior / Q000188:drug therapy* / Q000503:physiopathology; D014792:Visual Acuity / Q000187:drug effects; D014823:Vitreous Hemorrhage / Q000139:chemically induced
chemical_list: D000893:Anti-Inflammatory Agents; D004343:Drug Implants; D005446:Fluocinolone Acetonide